Epix Pharmaceuticals, Inc. (EPIX)

Trade EPIX now with
10/28/2019 7:36:55 AM ESSA Pharma Presents Data On EPI-7386 At AACR-NCI-EORTC International Conference
8/27/2019 9:25:32 AM ESSA Pharma Completes Public Offering And Concurrent Private Placement For Aggregate $36 Mln
8/14/2019 7:54:24 AM ESSA Pharma Q3 Net Loss $3.3 Mln Or $0.52/Shr Vs Loss Of $2.9 Mln Or $0.50/Shr Last Year
5/10/2019 7:39:50 AM ESSA Pharma Q2 Net Loss $3.4 Mln Or $0.54/Shr Vs Loss $4.4 Mln Or $0.83/Shr Last Year
12/13/2018 5:11:26 PM ESSA Pharma Q4 Loss/share $0.39 Vs. Loss $1.34 Year Ago
1/25/2018 11:25:29 PM ESSA Pharma: Frank Perabo To Depart As Chief Medical Officer To Pursue Other Opportunities, Effective Jan 31
1/16/2018 9:44:26 PM ESSA Expects 180-day Extension To Regain Compliance With The Nasdaq Bid Price Rule
12/15/2017 10:57:38 PM ESSA Announces Filing Of Prospectus Supplement And An Update To Previously Announced Equity Offering
9/11/2017 7:47:11 AM EPIX Pharmaceuticals Trading Halted; Expected To Resume At 8:00 AM ET
9/11/2017 7:37:58 AM ESSA Pharma Announces Results From Phase 1 Clinical Trial Of EPI-506; Updates Clinical And Strategic Plans
9/7/2017 7:48:04 AM ESSA Pharma Announces Abstract Presentation On EPI-506 At European Society For Medical Oncology 2017 Congress
7/21/2017 7:34:41 AM ESSA Pharma Reports Receipt Of NASDAQ Notice Of Market Value Deficiency